AccessPak for HIV PEP Expanded with Kaletra and LarkaDrin Capsules
Determining the interaction of AccessPak for HIV PEP Expanded with Kaletra and LarkaDrin Capsules and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: emtricitabine / lopinavir / ritonavir / tenofovir
Brand name: AccessPak for HIV PEP Expanded with Kaletra
Synonyms: n.a.
Generic Name: acetaminophen / dichloralphenazone / isometheptene mucate
Brand name: Nodolor
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- AccessPak for HIV PEP Expanded with Kaletra-Laronidase
- AccessPak for HIV PEP Expanded with Kaletra-Laronidase Intravenous
- AccessPak for HIV PEP Expanded with Kaletra-Larotrectinib
- AccessPak for HIV PEP Expanded with Kaletra-Larotrectinib Capsules
- AccessPak for HIV PEP Expanded with Kaletra-Larotrectinib Oral Solution
- AccessPak for HIV PEP Expanded with Kaletra-Larotrectinib Sulfate
- LarkaDrin Capsules-AccessPak for HIV PEP Expanded with Viracept
- LarkaDrin Capsules-Accolate
- LarkaDrin Capsules-Accretropin
- LarkaDrin Capsules-Accucaine
- LarkaDrin Capsules-AccuHist Drops
- LarkaDrin Capsules-AccuHist PDX Drops